Facebook
Twitter
Telegram
Report an ErrorNabriva Therapeutics plc Financial Statements 2011-2024 | NBRV
Annual Financial Statements Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.1 M | 787 K | 1.23 M | 1.04 B | 970 M | 1.98 B | 176 M | 179 M | - | - | - | - |
Shares |
2.68 M | 1.73 M | 514 K | 74.2 M | 50.8 M | 29.8 M | 2.15 M | 2.12 M | - | - | - | - |
Historical Prices |
1.53 | 0.454 | 2.39 | 13.5 | 19.8 | 51.4 | 108 | 90.1 | - | - | - | - |
Net Income |
-57.2 M | -49.4 M | -69.5 M | -82.8 M | -115 M | -74.4 M | -54.9 M | -31.4 M | -16.3 M | 15.5 M | - | - |
Revenue |
36.9 M | 28.9 M | 5.03 M | 7.75 M | 6.5 M | - | - | - | - | - | - | - |
Cost of Revenue |
28.6 M | 13.1 M | 766 K | 70 K | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 7.68 M | - | - | - | - | - | - | - | - |
Operating Income |
-55.5 M | -48.5 M | -66.1 M | -79.5 M | -114 M | -73.8 M | -55 M | -27.8 M | -10.7 M | - | - | - |
Interest Expense |
698 K | 901 K | 1.65 M | 3.39 M | 133 K | 43 K | 75 K | 22.1 M | 2.91 M | - | - | - |
EBITDA |
-55.3 M | -48.2 M | -65.7 M | -78.7 M | -114 M | -73.3 M | -54.4 M | -23.3 M | -9.75 M | 28.1 M | - | - |
Operating Expenses |
- | - | - | 87.2 M | 121 M | 73.8 M | - | - | - | - | - | - |
General and Administrative Expenses |
45.3 M | 51.6 M | 55.3 M | - | 41.7 M | 29.5 M | 13.4 M | 7.77 M | 3.46 M | 3.91 M | - | - |
All numbers in USD currency
Quarterly Income Statement Nabriva Therapeutics plc
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.2 M | 3.2 M | 2.73 M | - | 2.35 M | 2.27 M | 2.02 M | 40.6 M | 26.4 M | 21.1 M | 14.5 M | 11.3 M | 9.46 M | 9.45 M | 75.2 M | 72.5 M | 68.7 M | 67 M | 58.4 M | 40.5 M | 36.9 M | 36.7 M | 28.1 M | 27.2 M | 2.72 M | 2.72 M | 21.3 M | 21.3 M | 2.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-8.7 M | - | -11.5 M | -11.1 M | -11.8 M | - | -10.7 M | -11.8 M | -14 M | - | -13 M | -15.4 M | -23.3 M | -23 M | -17.8 M | -21.7 M | -20.2 M | -30.8 M | -52.8 M | -17.8 M | -13.3 M | -22.3 M | -22.3 M | -14.6 M | -15.2 M | -15.2 M | -14 M | -12.1 M | -13.6 M | -7.96 M | -8.42 M | -24.5 M | -6.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
7.59 M | - | 9.15 M | - | 8.02 M | - | 8.86 M | 8.24 M | 2.53 M | - | 1.29 M | 487 K | 789 K | 333 K | 6.92 M | 525 K | 1.7 M | 797 K | 461 K | 847 K | 7.55 M | 1.12 M | 1.47 M | 1.05 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
4.44 M | - | 4.42 M | - | 3.36 M | - | 4.2 M | 3.62 M | 62 K | - | 25 K | 368 K | 8 K | - | 15 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.48 M | - | -11.2 M | - | -11.6 M | - | -10.8 M | -11.4 M | -13.4 M | - | -13.2 M | -14.5 M | -20.2 M | -22.1 M | -17.2 M | -21 M | -19.2 M | -30.9 M | -52.9 M | -17.7 M | -12.9 M | -22.3 M | -20.7 M | -15.6 M | -15.2 M | -14.7 M | -14.1 M | -11.5 M | -14.7 M | -10.2 M | -8.33 M | -5.52 M | -3.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-31 K | - | 354 K | - | 308 K | - | 131 K | 241 K | 222 K | - | 256 K | 251 K | 1.02 M | - | 709 K | 904 K | 899 K | - | 8 K | 7 K | 4 K | - | 42 K | 3 K | 1 K | - | 35 K | - | 18 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-8.45 M | - | -11 M | - | -11.5 M | - | -10.5 M | -11.4 M | -13.3 M | - | -12.9 M | -14.2 M | -20.1 M | -22.1 M | -17 M | -20.7 M | -19.1 M | -30.9 M | -52.5 M | -17.4 M | -12.7 M | -22.3 M | -20.4 M | -15.4 M | -15.1 M | -14.7 M | -13.9 M | -11.4 M | -14.7 M | -10.2 M | -8.33 M | -5.52 M | -3.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.5 M | 20.9 M | 31.7 M | 53.4 M | 18.6 M | 20.4 M | 23.4 M | 22.2 M | 16.6 M | 16.9 M | 17 M | 15 M | 13.3 M | 16.1 M | 11.2 M | 9.62 M | 6.42 M | 4.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
9 M | - | 11.9 M | - | 12.7 M | - | 12.3 M | 12.9 M | 12 M | - | 11 M | 10.7 M | 16 M | - | 18.5 M | 13.4 M | 13.4 M | - | 12.6 M | 8.84 M | 10.1 M | - | 9.52 M | 5.57 M | 4.22 M | - | 2.99 M | 3.37 M | 3.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency